SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

7 Apr 2016 07:00

RNS Number : 4162U
Victrex PLC
07 April 2016
 
 

 

 

 

7 April 2016

Victrex plc: H1 pre-close trading update

'On track for expected H2 improvement'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first half year (H1) and pre-close trading update ahead of its interim results on 16 May 2016.

In line with the Group's guidance at its Q1 IMS, Victrex's first half year performance was down on the prior year. Q2 was robust with volumes excluding Consumer Electronics flat compared to the record prior year, despite the weaker performance in Oil & Gas.

The re-phasing of Consumer Electronics volumes to the second half year (H2), together with the tougher first half comparatives and worsening outlook in Oil & Gas, led to Group revenue declining by 11% to £117.0m (H1 2015: £131.6m). H1 Group volumes were down 13% to 1,770 tonnes (H1 2015: 2,028 tonnes).

We remain encouraged that the performance in our industrial markets outside of Electronics and Oil & Gas was solid, with Transport markets in growth. In our Medical business (Invibio), performance in our core Spine market was broadly similar to the prior year. Invibio revenue for the first half was £25.2m (H1 2015: £25.9m).

Our expectation for an improved second half year reflects both the robust Q2 performance and the re-phasing of Consumer Electronics volumes. Consumer Electronics volumes will be phased well into the second half, ahead of product launch cycles. This opportunity remains attractive for the current year and we expect to have a better view on the scale of volumes by our May interim results. This will provide a clearer view of whether Consumer Electronics has the potential to be similar to the second half of 2015.

David Hummel, Chief Executive of Victrex, said: "We retain our view of an overall improvement in the second half and are comfortable with current expectations for the full year as a whole."

 

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

 

Teneo Strategy:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the Automotive, Aerospace, Energy, Electronics and Medical markets. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUUCCUPQGAQ
Date   Source Headline
1st Dec 201712:51 pmRNSBlock listing Interim Review
30th Nov 20171:41 pmRNSTotal Voting Rights
27th Nov 201711:20 amRNSAdditional Listing
17th Nov 20173:57 pmRNSDirector/PDMR Shareholding
31st Oct 20179:41 amRNSTotal Voting Rights
17th Oct 20173:29 pmRNSDirector/PDMR Shareholding
29th Sep 201710:31 amRNSTotal Voting Rights
19th Sep 20172:59 pmRNSDirector/PDMR Shareholding
4th Sep 20177:01 amRNSCEO-designate update
4th Sep 20177:00 amRNSReduction in effective tax rate
31st Aug 20173:31 pmRNSTotal Voting Rights
17th Aug 201711:39 amRNSDirector/PDMR Shareholding
31st Jul 201710:36 amRNSTotal Voting Rights
25th Jul 20177:00 amRNSTrading Statement
18th Jul 20172:10 pmRNSDirector/PDMR Shareholding
30th Jun 20172:09 pmRNSTotal Voting Rights
19th Jun 20174:18 pmRNSDirector/PDMR Shareholding
1st Jun 20179:51 amRNSBlock listing Interim Review
31st May 20179:22 amRNSTotal Voting Rights
31st May 20179:05 amRNSHolding(s) in Company
19th May 20179:39 amRNSAdditional Listing
18th May 201710:23 amRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
28th Apr 20172:39 pmRNSTotal Voting Rights
19th Apr 20172:17 pmRNSDirector/PDMR Shareholding
19th Apr 20177:57 amRNSDirectorate Change
6th Apr 20177:00 amRNSAcquisition
31st Mar 201710:32 amRNSTotal Voting Rights
28th Mar 20177:00 amRNSCapital Markets Day
24th Mar 20172:44 pmRNSHolding(s) in Company
17th Mar 20172:12 pmRNSDirector/PDMR Shareholding
17th Mar 20179:34 amRNSHolding(s) in Company
14th Mar 201710:56 amRNSHolding(s) in Company
9th Mar 20174:33 pmRNSHolding(s) in Company
28th Feb 201710:49 amRNSTotal Voting Rights
17th Feb 201711:30 amRNSDirector/PDMR Shareholding
8th Feb 20171:59 pmRNSResult of AGM
8th Feb 20179:00 amRNSAudit Tender Notification
8th Feb 20177:00 amRNSAGM Statement
31st Jan 20173:54 pmRNSTotal Voting Rights
17th Jan 20172:52 pmRNSDirector/PDMR Shareholding
5th Jan 201711:31 amRNSAnnual Financial Report
30th Dec 201611:37 amRNSHolding(s) in Company
30th Dec 201610:00 amRNSTotal Voting Rights
21st Dec 20169:14 amRNSDirector Declaration
19th Dec 201612:54 pmRNSDirector/PDMR Shareholding
15th Dec 20169:02 amRNSDirector Declaration
8th Dec 20163:41 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSFinal Results
1st Dec 201611:53 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.